Table 1.
Demographic Characteristics and Evaluation Results.
| N=36 | Median (IQR) | Range |
|---|---|---|
| Age (years) | 55.00 (50.00-63.00) | 32-72 |
| Height (cm) | 157.50 (155.00-162.75) | 145-170 |
| Weight (kg) | 64.50 (58.50-75.75) | 48-93 |
| BMI (kg/m2) | 25.51 (24.05-29.03) | 19.47-38.04 |
| MSS | 4.00 (3.00-6.00) | 1-9 |
| mRSS | 4.50 (0-10.25) | 0-21 |
| FEV1 (L) | 1.94 (1.74-2.24) | 1.06-2.68 |
| FEV1 (% predicted) | 86.80 (75.37-99.20) | 44.70-120.20 |
| FVC (L) | 2.44 (2.13-2.80) | 1.20-3.24 |
| FVC (% predicted) | 93.20 (78.00-100.70) | 40.90-115.40 |
| FEV1 /FVC (%) | 82.60 (78.98-86.82) | 67.61-91.46 |
| TLC (L) | 4.34 (3.70-4.75) | 2.47-5.99 |
| TLC (%predicted) | 91.00 (76.55-99.90) | 48.00-135.00 |
| DLCO (L) | 5.84 (4.64-6.66) | 2.77-9.60 |
| DLCO (% predicted) | 70.00 (63.00-87.00) | 36.00-126.00 |
| Dominant quadriceps strength (kg) | 17.33 (15.04-20.11) | 11.50-25.60 |
| Dominant quadriceps strength (% predicted) | 60.14 (49.68-72.75) | 33.63-88.34 |
| HAQ | 0.25 (0.00- 0.56) | 0-1 |
| UCLA SCTC GIT-2 | 0.23 (0.08-0.41) | 0-1.25 |
| MAS | 640.50 (586.75-658.50) | 432-675 |
| IPAQ | 321.75 (145.50-664.12) | 0-1466 |
| 6MWD (m) | 430.00 (401.25-471.25) | 322.50-525.00 |
| 6 MWD (%predicted) | 84.99 (73.99-92.51) | 60.48-99.88 |
BMI: body mass index, FEV1: forced expiratory volume in the first second, FVC: forced vital capacity, TLC: total lung capacity, DLCO: diffusing capacity for carbon monoxide, MSS: Medsger Systemic Sclerosis Severity Scale, HAQ: Health Assessment Questionnaire, mRSS: modified Rodnan Skin Score, UCLA SCTC GIT 2: University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0, MAS: Milliken Activities of Daily Living Scale, IPAQ: International Physical Activity Questionnaire, 6MWD: Six Minute Walk Distance, IQR: interquartile range.